Colorectal
Learn about colorectal health, including prevention, screening, and treatment options for colorectal diseases. Stay informed on the latest advancements in colorectal cancer research.
Bristol Myers’ colorectal cancer drug significantly reduces relapse risk
Clinical trials indicate that Bristol Myers’ new drug effectively lowers the risk of cancer relapse in colorectal patients.
Pfizer announces successful trial results for colorectal cancer drug
Pfizer’s latest clinical trial shows promising results for its new colorectal cancer drug, marking a significant advancement in treatment options.
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation – Amgen (NASDAQ:AMGN) – Benzinga
Amgen’s Lumakras treatment, combined with Vectibix, is FDA-approved for KRAS G12C-mutated colorectal cancer.
Amgen Lumakras cleared for colorectal cancer (AMGN:NASDAQ) | Seeking Alpha
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more here.
We Spoke To A Colorectal Cancer Doctor Who Shared 5 Things We Should All Stop Doing Immediately
Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.
A Daily Glass of Milk Could Cut Colorectal Cancer Risk, Study Finds
Foods and drinks rich in calcium can reduce the risk of colon and rectal cancer, while red and processed meats and alcohol can raise the risk.
